User contributions for Kosar Doraghi

19 March 2024

• 21:4421:44, 19 March 2024 diff hist +43 Nedosiran No edit summary current

5 March 2024

• 01:4701:47, 5 March 2024 diff hist +21,576 Endocarditis overview No edit summary

28 February 2024

• 02:4002:40, 28 February 2024 diff hist +23,635 N Vonoprazan fumarate Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D.[mailto:k.doraghi@yahoo.com] |genericName=vonoprazan fumarate |aOrAn=a |drugClass=potassium-competitive acid blocker |indicationType=treatment |indication=all grades of erosive esophagitis and relief of heartburn associated with erosive esophagitis in adults. *to maintain healing of all grades of erosive esophagitis and relief of heartburn associated with erosive esophagitis in adults. *in combinatio..." current

24 February 2024

• 20:4420:44, 24 February 2024 diff hist +513 Template:KDRG No edit summary

23 February 2024

• 21:3621:36, 23 February 2024 diff hist +8,159 N Nedosiran Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=nedosiran |aOrAn=an |drugClass=LDHA-directed small interfering RNA |indicationType=treatment |indication=lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, e.g., eGFR ≥ 30 mL/min/1.73 m2 |adverseReactions=injection site reactions |fdaLIADAdult=RIVFLOZA Injection 160 mg/mL is a clear, colorless-t..."
• 21:2521:25, 23 February 2024 diff hist 0 N File:IMG 0866.jpeg No edit summary current
• 21:2421:24, 23 February 2024 diff hist 0 N File:IMG 0864.jpeg No edit summary current
• 21:2121:21, 23 February 2024 diff hist 0 N File:IMG 0858.jpeg No edit summary current
• 21:2021:20, 23 February 2024 diff hist 0 N File:IMG 0861.jpeg No edit summary current
• 21:2021:20, 23 February 2024 diff hist 0 N File:IMG 0860.jpeg No edit summary current
• 21:1921:19, 23 February 2024 diff hist 0 N File:IMG 0859.jpeg No edit summary current
• 21:1721:17, 23 February 2024 diff hist 0 N File:IMG 0867.jpeg No edit summary current
• 21:1121:11, 23 February 2024 diff hist 0 N File:IMG 0857.jpeg No edit summary current
• 21:0921:09, 23 February 2024 diff hist 0 N File:IMG 0856.jpeg No edit summary current
• 21:0621:06, 23 February 2024 diff hist 0 N File:IMG 0855.jpeg No edit summary current
• 21:0521:05, 23 February 2024 diff hist 0 N File:IMG 0853.jpeg No edit summary current
• 20:5320:53, 23 February 2024 diff hist 0 N File:IMG 0852.jpeg No edit summary current
• 04:1604:16, 23 February 2024 diff hist +15,630 N Nirogacestat Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=nirogacestat |aOrAn=a |drugClass=gamma secretase inhibitor |indicationType=treatment |indication=adult patients with progressing desmoid tumors who require systemic treatment |hasBlackBoxWarning=Yes |adverseReactions=diarrhea, ovarian toxicity, rash, nausea, fatigue, stomatitis, headache, abdominal pain, cough, alopecia, upper respiratory tract infection and [..."
• 04:0504:05, 23 February 2024 diff hist 0 N File:IMG 0851.jpeg No edit summary current
• 04:0004:00, 23 February 2024 diff hist 0 N File:IMG 0848.jpeg No edit summary current
• 03:5903:59, 23 February 2024 diff hist 0 N File:IMG 0850.jpeg No edit summary current
• 03:5703:57, 23 February 2024 diff hist 0 N File:IMG 0847.jpeg No edit summary current

16 February 2024

• 03:1503:15, 16 February 2024 diff hist +9,988 N Lasmiditan Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=Lasmiditan (REYVOW) |aOrAn=a |drugClass=serotonin (5-HT) 1F receptor agonist |indicationType=treatment |indication=migraine with or without aura in adults |hasBlackBoxWarning=Yes |adverseReactions=dizziness, fatigue, paresthesia, and sedation |blackBoxWarningTitle=Warning |blackBoxWarningBody=Driving Impairment: *Central Nervous System (CNS) Depression: Do not use in combination..."
• 03:0303:03, 16 February 2024 diff hist 0 N File:IMG 0837.jpeg No edit summary current
• 02:5802:58, 16 February 2024 diff hist 0 N File:IMG 0839.jpeg No edit summary current
• 02:5602:56, 16 February 2024 diff hist 0 N File:IMG 0838.jpeg No edit summary current

15 February 2024

• 02:4502:45, 15 February 2024 diff hist +16 Ponesimod No edit summary
• 01:0101:01, 15 February 2024 diff hist +19,062 N Ponesimod Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=Ponesimod (PONVORY) |aOrAn=a |drugClass=sphingosine 1-phosphate receptor modulator |indicationType=treatment |indication=relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults |hasBlackBoxWarning=Yes |adverseReactions=upper respiratory tract infection, hepatic transaminase elevation, and ..."
• 00:5600:56, 15 February 2024 diff hist 0 N File:IMG 0834.jpeg No edit summary current
• 00:5500:55, 15 February 2024 diff hist 0 N File:IMG 0833.jpeg No edit summary current
• 00:4900:49, 15 February 2024 diff hist 0 N File:IMG 0832.jpeg No edit summary current
• 00:4800:48, 15 February 2024 diff hist 0 N File:IMG 0829.jpeg No edit summary current
• 00:4600:46, 15 February 2024 diff hist 0 N File:IMG 0831.jpeg No edit summary current

14 February 2024

• 18:3018:30, 14 February 2024 diff hist +12,162 N Dasiglucagon Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=Dasiglucagon (ZEGALOGUE) |aOrAn=an |drugClass=anti-hypoglycemic |indicationType=treatment |indication=severe hypoglycemia in pediatric and adult patients with diabetes aged 6 years and older |hasBlackBoxWarning=Yes |adverseReactions=nausea, vomiting, headache, diarrhea, and injection site pain |blackBoxWarningTitle=Allergic reactions |blackBoxWarningBody=increase in blood pressure in Patients wi..."
• 18:1718:17, 14 February 2024 diff hist 0 N File:IMG 0828.jpeg No edit summary current
• 18:1618:16, 14 February 2024 diff hist 0 N File:IMG 0827.jpeg No edit summary current
• 18:1318:13, 14 February 2024 diff hist 0 N File:IMG 0822.jpeg No edit summary current
• 18:1218:12, 14 February 2024 diff hist 0 N File:IMG 0826.jpeg No edit summary current
• 18:0718:07, 14 February 2024 diff hist 0 N File:IMG 0824.jpeg No edit summary current
• 18:0518:05, 14 February 2024 diff hist 0 N File:IMG 0823.jpeg No edit summary current
• 17:5917:59, 14 February 2024 diff hist 0 N File:IMG 0820.jpeg No edit summary current
• 17:5817:58, 14 February 2024 diff hist 0 N File:IMG 0819.jpeg No edit summary current

13 February 2024

• 22:0022:00, 13 February 2024 diff hist +356 Vericiguat No edit summary
• 21:5721:57, 13 February 2024 diff hist 0 N File:IMG 0813.jpeg No edit summary current
• 21:5621:56, 13 February 2024 diff hist 0 N File:IMG 0812.jpeg No edit summary current
• 21:5421:54, 13 February 2024 diff hist 0 N File:IMG 0817.jpeg No edit summary current
• 21:5121:51, 13 February 2024 diff hist 0 N File:IMG 0818.jpeg No edit summary current
• 21:5021:50, 13 February 2024 diff hist 0 N File:IMG 0816.jpeg No edit summary current
• 21:4721:47, 13 February 2024 diff hist +11,303 N Vericiguat Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=VERQUVO-vericiguat |aOrAn=a |drugClass=soluble guanylate cyclase (sGC) stimulator |indicationType=treatment |indication=heart failure with reduced ejection fraction (HFrEF), reduce the risk of cardiovascular death and heart failure (HF) hospitalization following a hospitalization for heart failure or need for outpatient IV diuretics, in adults with symptomatic chronic HF and ejection fraction less t..."
• 21:4321:43, 13 February 2024 diff hist 0 N File:IMG 0815.jpeg No edit summary current